Investment Insights
We partner with Hedge Funds, Private Equity houses, Venture Capital firms, Private / Angel investors, startups and entrepreneurs, providing timely and actionable research and insights that yield a competitive advantage.
From uncovering hidden investment opportunities and identifying emerging investment trends, to supporting a due-diligence process with crucial intelligence, we can provide timely and insightful recommendations for our clients.
Our insights and advisory focus on:
- Landscape analysis, including scientific and commercial due diligence
- Company / asset profiling, including addressable market size, growth drivers and expected growth, segmentation, value proposition etc.
- Decision-making opportunity / risk assessment, both for investors and their portfolio companies
- Other research and advisory, customized to our clients’ needs
We also provide fundraising services, by connecting entrepreneurs and companies who seek the all-important capital to kick-start or grow their venture with potential investors from our extensive network of contacts.
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, related to trending news from the investment space.
Want to make informed investments and capitalize on key opportunities? Let’s connect!
Reach out to info@lqventures.com to learn more about our strategic consulting and research capabilities.
October 15, 2025
Lucid Diligence Brief: Verily UCHealth AI collaboration
October 15, 2025
Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)
October 15, 2025
Top Neuroscience News: Video summary (Oct 1 –14, 2025)
October 15, 2025
Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)
October 15, 2025
Lucid Diligence Brief: Kailera Therapeutics $600m Series B
October 14, 2025
Neuroscience Today: Roche & Lilly Lead in Alzheimer’s (Oct 7 –14, 2025)
October 14, 2025
Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)
October 14, 2025
Obesity Today: Chugai licenses CT-388 for Japan, GLP-1 access news (Oct 7–14, 2025)
October 14, 2025
Endocrinology Today : SMOC1 impact on T2D and more breakthroughs (Oct 7–14, 2025)
October 14, 2025
Lucid Diligence Brief: Excellergy ECRIs, $70M investment
October 13, 2025
Top Oncology News: Video summary (Sept 29 – Oct 13, 2025)
October 13, 2025